Home » Authors » Anette Breindl

Articles by Anette Breindl

After Study, Doctors Unclear On Clinical Risks For Gene Therapy

May 22, 2006

By Anette Breindl

After Study, Doctors Unclear On Clinical Risks For Gene Therapy

May 22, 2006

By Anette Breindl

Noncoding DNA Has Role In Silencing Of X Chromosome

May 18, 2006

By Anette Breindl

Noncoding DNA Has Role In Silencing Of X Chromosome

May 18, 2006

By Anette Breindl

New Models Hopefully Spell End Of One-Size-Fits-All Era

May 12, 2006

By Anette Breindl

New Models Hopefully Spell End Of One-Size-Fits-All Era

May 12, 2006

By Anette Breindl

Surrogate Endpoints, FDA Drugs, 'Disease Mongering'

May 8, 2006

By Anette Breindl and Aaron Lorenzo

Expanding Fusion's Potential By Delivering Health Triplets

May 3, 2006

By Anette Breindl

Expanding Fusion's Potential By Delivering Health Triplets

May 3, 2006

By Anette Breindl

'Flipping' Providing New Way For Payload Delivery To Cells

April 25, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...